Risk of Gene-Fusion Positive Prostate Cancer is Lower Among Obese by Kocarnik, Jonathan
May 18, 2015 SCIENCE SPOTLIGHT 
 
1 Volume 5, Issue 5 | Fred Hutchinson Cancer Research Center 
 
Risk of Gene-Fusion Positive Prostate Cancer is 
Lower Among Obese 
May 18, 2015 
    JM Kocarnik 
Approximately 50% of prostate cancers harbor a T2E gene fusion. As an early driver of prostate 
carcinogenesis, this gene fusion may characterize distinct molecular subtypes of prostate cancer 
with different etiologies.  It is not known, however, whether lifestyle factors such as obesity have 
different associations with prostate cancer risk depending on this molecular characterization.  In a 
recent study in theAmerican Journal of Epidemiology, Ms. Lieke Egbers and Dr. Janet Stanford and 
colleagues in the Public Health Sciences Division provide evidence that obesity is associated with a 
reduced risk of androgen-regulated T2E fusion-positive tumors, but not with T2E fusion-negative 
tumors. 
The T2E gene fusion consists of the fusion of the transmembrane protease, serine 2 (TMPRSS2) 
and erythroblast transformation-specific-related (ERG) genes. TMPRSS2 harbors androgen-
responsive elements in the promoter region, while ERG encodes a nuclear protein that acts as a 
transcription factor.  Androgens have been implicated in the induction of these fusion events, which 
once fused leads to overexpression of ERG and disruption of androgen receptor signaling.  As 
obesity alters the circulating levels of sex hormones compared to normal-weight men, including 
lowering androgen levels, the authors hypothesized that obesity may decrease the risk of T2E gene 
fusion-positive prostate tumors. 
The authors measured T2E gene fusion status in 563 prostate cancer tumors, using tumor tissue 
from two population-based case-control studies conducted in the King County, Washington 
area.  "The ability to obtain formalin-fixed paraffin embedded (FFPE) tumor tissue blocks and utilize 
the latest technologies for molecular profiling of such tissues is key for this type of molecular 
epidemiologic research," said lead author Ms. Egbers.  The association between quartiles of body 
mass index (BMI) and prostate cancer risk was then evaluated according to fusion status.  "This 
ability to stratify prostate cancer cases according to tumor molecular subtype (such as T2E fusion 
status) now allows us to study etiologic heterogeneity, with different molecular subtypes having 
distinct risk factor profiles," said Ms. Egbers.  
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Comparing the highest BMI quartile with the lowest, the authors found an inverse association with 
the risk of T2E-positive prostate cancer, but no association was seen with risk of T2E-negative 
prostate cancer (see figure).  Other characterizations of obesity were consistent with this finding, 
such as evaluating standard WHO BMI categories (obese vs. normal) or BMI as a continuous 
variable (in 5-unit increments).  "These data provide new evidence that these different molecular 
subtypes of prostate cancer may have different etiologies," said Ms. Egbers.  
"At present the biological mechanism by which obesity decreases risk for T2E positive prostate 
cancer, but not for T2E negative tumors, is not known," said Ms. Egbers.  "Since the T2E fusion is 
responsive to androgens, we hypothesize that the altered steroid hormone profile in obese men 
(e.g., lower circulating levels of androgens) may contribute to the reduction in risk for T2Epositive 
prostate cancer. Further research will be needed to explore the biological mechanism behind this 
finding."  Understanding these etiological differences may lead to better understanding of risk factors 
for particular subtypes of prostate cancer, which should eventually lead to improvements in 
prevention, screening, and treatment. 
Other PHS researchers contributing to this project were Drs. Jonathan Wright and Marian 
Neuhouser, as well as Ms. Suzanne Kolb. 
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Image provided by Ms. Lieke Egbers 
Association of quartiles of body mass index (compared to the lowest 
quartile) with risk of T2E negative (top) or positive (bottom) prostate 
cancer. 
 
